Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05065710
What this trial is testing

ZL-1211 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Zai Biopharmaceutical (Suzhou) Co., Ltd. 34
Not applicableUnknownNCT03704597
What this trial is testing

Cryotherapy Against Oral Mucositis After High-dose Melphalan

Who this might be right for
MyelomaMucositisCryotherapy Effect
Sahlgrenska University Hospital 100
Large-scale testing (Phase 3)Study completedNCT02892149
What this trial is testing

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)

Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 3,554
Large-scale testing (Phase 3)Study completedNCT01822548
What this trial is testing

Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Azienda Ospedaliero-Universitaria di Parma 64
Early research (Phase 1)Study completedNCT00921726
What this trial is testing

Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 17
Testing effectiveness (Phase 2)Looking for participantsNCT05636215
What this trial is testing

A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 368
Testing effectiveness (Phase 2)Study completedNCT04014335
What this trial is testing

Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Ionis Pharmaceuticals, Inc. 23
Early research (Phase 1)Active Not RecruitingNCT02808208
What this trial is testing

Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure

Who this might be right for
End Stage Renal Disease (ESRD)Vascular Access Complication
Mayo Clinic 74
Large-scale testing (Phase 3)Study completedNCT02201108
What this trial is testing

Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Genzyme, a Sanofi Company 166
Testing effectiveness (Phase 2)Study completedNCT03389308
What this trial is testing

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa Simplex
Castle Creek Pharmaceuticals, LLC 51
Testing effectiveness (Phase 2)Looking for participantsNCT06667908
What this trial is testing

JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Johnson & Johnson Enterprise Innovation Inc. 130
Large-scale testing (Phase 3)Study completedNCT04143217
What this trial is testing

Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
Supernus Pharmaceuticals, Inc. 159
Testing effectiveness (Phase 2)Study completedNCT03623750
What this trial is testing

E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Instituto Oncológico Dr Rosell 23
Early research (Phase 1)Study completedNCT02215850
What this trial is testing

Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours

Who this might be right for
Solid Tumours
Welichem Biotech Inc. 24
Post-approval studies (Phase 4)Ended earlyNCT00894790
What this trial is testing

Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident

Who this might be right for
Pain
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 8
Not applicableWithdrawnNCT05639790
What this trial is testing

The Effectiveness of Using E-Cigarettes for Smoking Cessation and Decreasing Risk of Diseases Among Heavy Smokers

Who this might be right for
Smoking Cessation
Shenzhen Smoore Technology Limited
Early research (Phase 1)Not Yet RecruitingNCT07799597
What this trial is testing

Comparison of HBW-3220 Capsule Formulations and the Effect of Food in Healthy Participants

Who this might be right for
Healthy Volunteers
The Third Xiangya Hospital of Central South University 21
Large-scale testing (Phase 3)Looking for participantsNCT05726110
What this trial is testing

Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
Shanxi Bethune Hospital 50
Early research (Phase 1)Not Yet RecruitingNCT07374510
What this trial is testing

Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Sinovac Life Sciences Co., Ltd. 150
Post-approval studies (Phase 4)Active Not RecruitingNCT06795048
What this trial is testing

Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Hoffmann-La Roche 274
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation